US5292668A
(en)
|
1981-12-21 |
1994-03-08 |
Boston Biomedical Research Institute, Inc. |
Bispecific antibody determinants
|
US5869620A
(en)
|
1986-09-02 |
1999-02-09 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
FR2604092B1
(fr)
|
1986-09-19 |
1990-04-13 |
Immunotech Sa |
Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
|
WO1989001159A1
(en)
|
1987-07-27 |
1989-02-09 |
Commonwealth Scientific And Industrial Research Or |
Receptor membranes
|
US4943525A
(en)
|
1987-11-02 |
1990-07-24 |
Bioventures, Inc. |
Simultaneous immunoassay for the determination of antigens and antibodies
|
US5869053A
(en)
|
1988-03-04 |
1999-02-09 |
Cancer Research Campaign Technology, Ltd. |
5T4 antigen from human trophoblasts
|
US4892824A
(en)
|
1988-03-15 |
1990-01-09 |
Synbiotics Corporation |
Fast track method for producing monoclonal bi-specific immunoglobulins
|
US6010902A
(en)
|
1988-04-04 |
2000-01-04 |
Bristol-Meyers Squibb Company |
Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
|
US5851527A
(en)
|
1988-04-18 |
1998-12-22 |
Immunomedics, Inc. |
Method for antibody targeting of therapeutic agents
|
ES2052027T5
(es)
|
1988-11-11 |
2005-04-16 |
Medical Research Council |
Clonacion de secuencias de dominio variable de inmunoglobulina.
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
US5980896A
(en)
|
1989-06-30 |
1999-11-09 |
Bristol-Myers Squibb Company |
Antibodies reactive with human carcinomas
|
US5332567A
(en)
|
1989-08-24 |
1994-07-26 |
Immunomedics |
Detection and treatment of infections with immunoconjugates
|
US5582996A
(en)
|
1990-12-04 |
1996-12-10 |
The Wistar Institute Of Anatomy & Biology |
Bifunctional antibodies and method of preparing same
|
US6197298B1
(en)
|
1991-04-19 |
2001-03-06 |
Tanox, Inc. |
Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals
|
DE4118120A1
(de)
|
1991-06-03 |
1992-12-10 |
Behringwerke Ag |
Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung
|
US5637481A
(en)
|
1993-02-01 |
1997-06-10 |
Bristol-Myers Squibb Company |
Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
|
DE4134982A1
(de)
|
1991-10-23 |
1993-04-29 |
Kernforschungsz Karlsruhe |
Verwendung von antikoerper enthaltenden praeparationen zur immunsuppression
|
US5932448A
(en)
|
1991-11-29 |
1999-08-03 |
Protein Design Labs., Inc. |
Bispecific antibody heterodimers
|
DE4140142A1
(de)
|
1991-12-05 |
1993-06-09 |
Boehringer Mannheim Gmbh, 6800 Mannheim, De |
Multivalentes dextranreagenz zum einsatz in praezipitationstests
|
JPH08503121A
(ja)
|
1991-12-10 |
1996-04-09 |
デイナ・フアーバー・キヤンサー・インステイテユート |
中和反応性ヒト抗−gp120組換え抗体、それをコードするdnaおよびその使用
|
US5766886A
(en)
*
|
1991-12-13 |
1998-06-16 |
Xoma Corporation |
Modified antibody variable domains
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
AU675929B2
(en)
|
1992-02-06 |
1997-02-27 |
Curis, Inc. |
Biosynthetic binding protein for cancer marker
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
US6096289A
(en)
|
1992-05-06 |
2000-08-01 |
Immunomedics, Inc. |
Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy
|
DE69334287D1
(de)
|
1992-09-25 |
2009-07-09 |
Avipep Pty Ltd |
Zielmoleküle-bindende Polypeptide bestehend aus einer IG-artigen VL Domäne die an eine IG-artige VH Domäne gebunden ist
|
US20080152586A1
(en)
|
1992-09-25 |
2008-06-26 |
Avipep Pty Limited |
High avidity polyvalent and polyspecific reagents
|
WO1994008038A1
(en)
|
1992-10-02 |
1994-04-14 |
Trustees Of Dartmouth College |
Bispecific reagents for redirected targeting of low density lipoprotein
|
DE69232604T2
(de)
|
1992-11-04 |
2002-11-07 |
City Of Hope Duarte |
Antikörperkonstrukte
|
US6953668B1
(en)
|
1992-11-05 |
2005-10-11 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
ATE342356T1
(de)
|
1992-11-05 |
2006-11-15 |
Sloan Kettering Inst Cancer |
Prostata-spezifisches membranantigen
|
US7105159B1
(en)
|
1992-11-05 |
2006-09-12 |
Sloan-Kettering Institute For Cancer Research |
Antibodies to prostate-specific membrane antigen
|
US7070782B1
(en)
|
1992-11-05 |
2006-07-04 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
WO1994012520A1
(en)
|
1992-11-20 |
1994-06-09 |
Enzon, Inc. |
Linker for linked fusion polypeptides
|
US5376249A
(en)
|
1992-11-25 |
1994-12-27 |
Perseptive Biosystems, Inc. |
Analysis utilizing isoelectric focusing
|
US5837242A
(en)
|
1992-12-04 |
1998-11-17 |
Medical Research Council |
Multivalent and multispecific binding proteins, their manufacture and use
|
GB9225453D0
(en)
|
1992-12-04 |
1993-01-27 |
Medical Res Council |
Binding proteins
|
SG55079A1
(en)
|
1992-12-11 |
1998-12-21 |
Dow Chemical Co |
Multivalent single chain antibodies
|
US5861156A
(en)
|
1993-01-08 |
1999-01-19 |
Creative Biomolecules |
Methods of delivering agents to target cells
|
US5705614A
(en)
|
1993-04-09 |
1998-01-06 |
Chiron Corporation |
Methods of producing antigen forks
|
US6491916B1
(en)
|
1994-06-01 |
2002-12-10 |
Tolerance Therapeutics, Inc. |
Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies
|
UA40577C2
(uk)
*
|
1993-08-02 |
2001-08-15 |
Мерк Патент Гмбх |
Біспецифічна молекула, що використовується для лізису пухлинних клітин, спосіб її одержання, моноклональне антитіло (варіанти), фармацевтичний препарат, фармацевтичний набір (варіанти), спосіб видалення пухлинних клітин
|
KR100398819B1
(ko)
|
1993-09-02 |
2004-02-05 |
트러스티스 오브 다트마우스 칼리지 |
gp39길항제를포함하는약제조성물
|
US5869049A
(en)
|
1993-09-02 |
1999-02-09 |
Trustees Of Dartmouth College |
Methods of inducing T cell unresponsiveness to bone marrow with gp39 antagonists
|
US5935818A
(en)
|
1995-02-24 |
1999-08-10 |
Sloan-Kettering Institute For Cancer Research |
Isolated nucleic acid molecule encoding alternatively spliced prostate-specific membrane antigen and uses thereof
|
US6569432B1
(en)
|
1995-02-24 |
2003-05-27 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
GB9324807D0
(en)
|
1993-12-03 |
1994-01-19 |
Cancer Res Campaign Tech |
Tumour antibody
|
DE4421391C1
(de)
|
1994-06-18 |
1995-11-30 |
Gsf Forschungszentrum Umwelt |
Verwendung von Antikörpern gegen T-Zellen zur verlängerten Immunsuppression
|
US5559099A
(en)
|
1994-09-08 |
1996-09-24 |
Genvec, Inc. |
Penton base protein and methods of using same
|
US5541087A
(en)
|
1994-09-14 |
1996-07-30 |
Fuji Immunopharmaceuticals Corporation |
Expression and export technology of proteins as immunofusins
|
US5688690A
(en)
|
1994-09-16 |
1997-11-18 |
The Wistar Institute Of Anatomy And Biology |
Human cytotoxic lymphocyte signal transduction surface protein (P38) and monoclonal antibodies thereto
|
CA2212846A1
(en)
|
1995-02-24 |
1996-08-29 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
GB9504344D0
(en)
|
1995-03-03 |
1995-04-19 |
Unilever Plc |
Antibody fragment production
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
US5747035A
(en)
|
1995-04-14 |
1998-05-05 |
Genentech, Inc. |
Polypeptides with increased half-life for use in treating disorders involving the LFA-1 receptor
|
AUPO591797A0
(en)
|
1997-03-27 |
1997-04-24 |
Commonwealth Scientific And Industrial Research Organisation |
High avidity polyvalent and polyspecific reagents
|
US5773292A
(en)
|
1995-06-05 |
1998-06-30 |
Cornell University |
Antibodies binding portions, and probes recognizing an antigen of prostate epithelial cells but not antigens circulating in the blood
|
US5830478A
(en)
|
1995-06-07 |
1998-11-03 |
Boston Biomedical Research Institute |
Method for delivering functional domains of diphtheria toxin to a cellular target
|
US5989830A
(en)
|
1995-10-16 |
1999-11-23 |
Unilever Patent Holdings Bv |
Bifunctional or bivalent antibody fragment analogue
|
CA2235269C
(en)
|
1995-10-19 |
2006-09-19 |
Bristol-Myers Squibb Company |
Monoclonal antibody br110 and uses thereof
|
US20040253246A1
(en)
|
1996-02-23 |
2004-12-16 |
Israeli Ron S. |
Prostate-specific membrane antigen and uses thereof
|
ATE318147T1
(de)
|
1996-03-25 |
2006-03-15 |
Medarex Inc |
Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
|
US6150508A
(en)
|
1996-03-25 |
2000-11-21 |
Northwest Biotherapeutics, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
US6107090A
(en)
|
1996-05-06 |
2000-08-22 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
|
US6136311A
(en)
*
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
EP0901630B1
(en)
|
1996-05-23 |
2003-08-20 |
Inverness Medical Switzerland GmbH |
Improvements in or relating to specific binding assays
|
AU729029B2
(en)
|
1996-07-03 |
2001-01-25 |
Genentech Inc. |
Hepatocyte growth factor receptor agonists and uses thereof
|
GB9712818D0
(en)
|
1996-07-08 |
1997-08-20 |
Cambridge Antibody Tech |
Labelling and selection of specific binding molecules
|
US5922845A
(en)
|
1996-07-11 |
1999-07-13 |
Medarex, Inc. |
Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
|
AU729515B2
(en)
|
1996-10-17 |
2001-02-01 |
Immunomedics Inc. |
Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
|
JP4663824B2
(ja)
|
1996-12-31 |
2011-04-06 |
ハイ スループット ジェノミクス インコーポレイテッド |
多重化分子分析装置および方法
|
US6541212B2
(en)
|
1997-03-10 |
2003-04-01 |
The Regents Of The University Of California |
Methods for detecting prostate stem cell antigen protein
|
EP0977837A1
(en)
|
1997-04-03 |
2000-02-09 |
Universite Laval |
Transgenic expression in genital tract and sexual accessory glands
|
WO1999002567A2
(en)
|
1997-07-08 |
1999-01-21 |
Board Of Regents, The University Of Texas System |
Compositions and methods for producing homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells
|
US6994851B1
(en)
|
1997-07-10 |
2006-02-07 |
Mannkind Corporation |
Method of inducing a CTL response
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
WO1999011590A1
(en)
|
1997-09-03 |
1999-03-11 |
Immunomedics, Inc. |
Fluorination of proteins and peptides for f-18 positron emission tomography
|
US6030792A
(en)
|
1997-11-13 |
2000-02-29 |
Pfizer Inc |
Assays for measurement of protein fragments in biological media
|
US6709844B1
(en)
|
2000-11-16 |
2004-03-23 |
Mannkind Corporation |
Avoidance of undesirable replication intermediates in plasmid propagation
|
DE19911329A1
(de)
|
1998-03-27 |
2000-09-21 |
Benes Ivan Friedrich |
Humantherapeutisch anwendbares Radioimmunkonjugat und Verfahren zu seiner Herstellung
|
HUP9900956A2
(hu)
|
1998-04-09 |
2002-04-29 |
Aventis Pharma Deutschland Gmbh. |
Egyláncú, több antigéntkötőhely kialakítására képes molekulák, előállításuk és alkalmazásuk
|
PT1071700E
(pt)
|
1998-04-20 |
2010-04-23 |
Glycart Biotechnology Ag |
Modificação por glicosilação de anticorpos para melhorar a citotoxicidade celular dependente de anticorpos
|
US6200765B1
(en)
|
1998-05-04 |
2001-03-13 |
Pacific Northwest Cancer Foundation |
Non-invasive methods to detect prostate cancer
|
US6071490A
(en)
|
1998-05-07 |
2000-06-06 |
Immunomedics, Inc. |
Position emission tomography using gallium-68 chelates
|
EP1079862B1
(en)
|
1998-05-20 |
2010-07-07 |
Immunomedics, Inc. |
Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
|
US20060052321A1
(en)
|
2002-04-05 |
2006-03-09 |
Raitano Arthur B |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US20030149531A1
(en)
|
2000-12-06 |
2003-08-07 |
Hubert Rene S. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US20040141975A1
(en)
|
1998-06-01 |
2004-07-22 |
Raitano Arthur B. |
Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
|
DK1086223T3
(da)
|
1998-06-01 |
2009-11-30 |
Agensys Inc |
Nye serpentintransmembranantigener udtrykt i humane cancerformer og anvendelser deraf
|
JP2002520297A
(ja)
|
1998-07-13 |
2002-07-09 |
ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システム |
アミノリン脂質に結合する治療結合体を用いる癌処置方法
|
WO2000014234A1
(en)
|
1998-09-08 |
2000-03-16 |
Urocor, Inc. |
Prostate specific promoter and regulation of gene expression
|
US6361774B1
(en)
|
1999-09-17 |
2002-03-26 |
Immunomedics, Inc. |
Methods and compositions for increasing the target-specific toxicity of a chemotherapy drug
|
WO2000018888A1
(en)
|
1998-09-29 |
2000-04-06 |
The Uab Research Foundation |
Immunomodulation by genetic modification of dendritic cells and b-cells
|
WO2000034461A2
(en)
|
1998-12-10 |
2000-06-15 |
Board Of Regents, The University Of Texas System |
Compositions and methods of modulating cholesterol metabolism
|
CA2370237A1
(en)
|
1999-04-13 |
2000-10-19 |
Northwest Biotherapeutics, Inc. |
Methods for the diagnosis and treatment of metastatic prostate tumors
|
KR100816572B1
(ko)
|
1999-04-28 |
2008-03-24 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
항-vegf 항체 및 이를 포함하는 약제학적 조성물
|
WO2001009303A2
(en)
|
1999-07-30 |
2001-02-08 |
Vical Inc. |
Flt-3 LIGAND-ENCODING POLYNUCLEOTIDE AS A POLYNUCLEOTIDE-BASED VACCINE ENHANCER
|
NZ523206A
(en)
|
1999-08-31 |
2004-12-24 |
Genentech Inc |
Antibodies that bind to tumor gene sequences
|
US6342587B1
(en)
|
1999-10-22 |
2002-01-29 |
Ludwig Institute For Cancer Research |
A33 antigen specific immunoglobulin products and uses thereof
|
US6824780B1
(en)
|
1999-10-29 |
2004-11-30 |
Genentech, Inc. |
Anti-tumor antibody compositions and methods of use
|
EP1268550A2
(en)
|
2000-03-17 |
2003-01-02 |
Boehringer Ingelheim Pharma KG |
Human fap-alpha-specific antibodies
|
AU2001260153B2
(en)
|
2000-03-24 |
2006-08-17 |
Micromet Ag |
Multifunctional polypeptides comprising a binding site to an epitope of the NKG2D receptor complex
|
US6573096B1
(en)
|
2000-04-01 |
2003-06-03 |
The Research Foundation At State University Of New York |
Compositions and methods for inhibition of cancer invasion and angiogenesis
|
NZ521540A
(en)
|
2000-04-11 |
2004-09-24 |
Genentech Inc |
Multivalent antibodies and uses therefor
|
EP2278023A1
(en)
|
2000-04-28 |
2011-01-26 |
Mannkind Corporation |
Epitope cluster from Melan-A/MART-1 for the induction of anti-tumor immunogenicity
|
US6861234B1
(en)
|
2000-04-28 |
2005-03-01 |
Mannkind Corporation |
Method of epitope discovery
|
US6375991B1
(en)
|
2000-09-08 |
2002-04-23 |
Albemarle Corporation |
Production of concentrated biocidal solutions
|
DE10045591A1
(de)
|
2000-09-15 |
2002-04-04 |
Klaus Pfizenmaier |
Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine)
|
US7666414B2
(en)
|
2001-06-01 |
2010-02-23 |
Cornell Research Foundation, Inc. |
Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen
|
WO2002098897A2
(en)
|
2001-06-01 |
2002-12-12 |
Cornell Research Foundation, Inc. |
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
US7514078B2
(en)
|
2001-06-01 |
2009-04-07 |
Cornell Research Foundation, Inc. |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
|
CA2838062C
(en)
|
2001-08-03 |
2015-12-22 |
Roche Glycart Ag |
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
|
CN1142183C
(zh)
*
|
2001-08-23 |
2004-03-17 |
北京大学人民医院 |
抗独特型微抗体及其制备方法和应用
|
JP2005505271A
(ja)
|
2001-09-06 |
2005-02-24 |
アジェンシス, インコーポレイテッド |
癌の処置および検出において有用なsteap−1と名称が与えられる核酸および対応するタンパク質
|
US7494646B2
(en)
|
2001-09-06 |
2009-02-24 |
Agensys, Inc. |
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
|
WO2003024388A2
(en)
|
2001-09-20 |
2003-03-27 |
Cornell Research Foundation, Inc. |
Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
|
AU2002337935B2
(en)
|
2001-10-25 |
2008-05-01 |
Genentech, Inc. |
Glycoprotein compositions
|
GB0126378D0
(en)
|
2001-11-02 |
2002-01-02 |
Oxford Biomedica Ltd |
Antigen
|
CN101024842A
(zh)
|
2001-11-07 |
2007-08-29 |
曼康公司 |
编码靶相关抗原表位的表达载体及其设计方法
|
US20040018519A1
(en)
|
2001-11-16 |
2004-01-29 |
Wright ,Jr. George L |
Methods and devices for quantitative detection of prostate specific membrane antigen and other prostatic markers
|
AU2002351353A1
(en)
|
2001-12-19 |
2003-09-02 |
Genentech, Inc. |
Stabilizing polypeptides which have been exposed to urea
|
ATE417858T1
(de)
|
2002-02-05 |
2009-01-15 |
Genentech Inc |
Proteinaufreinigung
|
CA2481401A1
(en)
|
2002-04-15 |
2003-10-30 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to tl5
|
JP4319979B2
(ja)
|
2002-04-26 |
2009-08-26 |
ジェネンテック・インコーポレーテッド |
タンパク質の非アフィニティ精製
|
AU2003278161A1
(en)
|
2002-06-21 |
2004-01-06 |
Johns Hopkins University School Of Medicine |
Membrane associated tumor endothelium markers
|
US9809654B2
(en)
|
2002-09-27 |
2017-11-07 |
Vaccinex, Inc. |
Targeted CD1d molecules
|
US7820166B2
(en)
|
2002-10-11 |
2010-10-26 |
Micromet Ag |
Potent T cell modulating molecules
|
US9701754B1
(en)
|
2002-10-23 |
2017-07-11 |
City Of Hope |
Covalent disulfide-linked diabodies and uses thereof
|
AU2004205802B2
(en)
|
2003-01-22 |
2009-11-05 |
Roche Glycart Ag |
Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
|
US20050026178A1
(en)
|
2003-03-28 |
2005-02-03 |
Marit Nilsen-Hamilton |
Allosteric probes and methods
|
GB0308988D0
(en)
|
2003-04-17 |
2003-05-28 |
Univ Singapore |
Molecule
|
US7541442B2
(en)
|
2003-05-30 |
2009-06-02 |
Agensys, Inc. |
Antibodies and related molecules that bind to PSCA proteins
|
CN101090729B
(zh)
|
2003-05-30 |
2014-07-23 |
艾更斯司股份有限公司 |
前列腺干细胞抗原(psca)变体及其序列
|
US7595379B2
(en)
|
2003-05-30 |
2009-09-29 |
Agensys, Inc. |
Antibodies and related molecules that bind to PSCA proteins
|
CA2523716C
(en)
|
2003-05-31 |
2014-11-25 |
Micromet Ag |
Human anti-human cd3 binding molecules
|
EP1641826A2
(en)
|
2003-06-27 |
2006-04-05 |
Biogen Idec MA Inc. |
Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
|
HUE050171T2
(hu)
|
2003-07-28 |
2020-11-30 |
Genentech Inc |
Protein-A kioldódásának csökkentése protein-A affinitáskromatográfia során
|
GB0321805D0
(en)
|
2003-09-18 |
2003-10-15 |
Univ Wales Medicine |
Human tumour growth patterns
|
US7524813B2
(en)
|
2003-10-10 |
2009-04-28 |
Novo Nordisk Health Care Ag |
Selectively conjugated peptides and methods of making the same
|
BRPI0415457A
(pt)
|
2003-10-16 |
2006-12-05 |
Micromet Ag |
constructo de ligação especìfico de cd3 citotoxicamente ativo, seu processo de produção, composição compreendendo o mesmo, seqüência de ácido nucléico, vetor, hospedeiro, seus usos na preparação de uma composição farmacêutica e kit compreendendo os mesmo
|
EP2633866A3
(en)
|
2003-10-17 |
2013-12-18 |
Novo Nordisk A/S |
Combination therapy
|
ITPD20030264A1
(it)
|
2003-10-30 |
2005-04-30 |
Xeptagen Spa |
Metodo di diagnosi altamente specifico per neoplasie
|
BR122018071808B8
(pt)
|
2003-11-06 |
2020-06-30 |
Seattle Genetics Inc |
conjugado
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
CA2553261C
(en)
|
2004-01-16 |
2014-03-18 |
Stefan Barth |
Immunokinases
|
JP4762158B2
(ja)
|
2004-02-16 |
2011-08-31 |
ミクロメット・アクチェンゲゼルシャフト |
低い免疫原性を有する結合分子
|
EP1718667B1
(en)
|
2004-02-23 |
2013-01-09 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
EP1610818A4
(en)
|
2004-03-03 |
2007-09-19 |
Millennium Pharm Inc |
MODIFIED ANTIBODIES AGAINST A PROSTATE-SPECIFIC MEMBRANE-ANTIGEN AND USE THEREOF
|
ES2549077T3
(es)
|
2004-04-07 |
2015-10-22 |
Genentech, Inc. |
Espectrometría de masas de conjugados de anticuerpos
|
BRPI0418766B8
(pt)
|
2004-04-22 |
2021-05-25 |
Agensys Inc |
anticorpo ou seu fragmento, vetor, composição farmacêutica, ensaio e método para detectar a presença de proteína steap-1, bem como método para distribuir um agente citotóxico ou um agente de diagnóstico
|
KR101200133B1
(ko)
|
2004-06-01 |
2012-11-13 |
제넨테크, 인크. |
항체 약물 접합체 및 방법
|
US20080227736A1
(en)
|
2004-06-03 |
2008-09-18 |
Regents Of The University Of California, |
Targeting Pseudotyped Retroviral Vectors
|
US20060159689A1
(en)
|
2004-06-17 |
2006-07-20 |
Chih-Sheng Chiang |
Combinations of tumor-associated antigens in diagnostics for various types of cancers
|
EA010374B1
(ru)
|
2004-07-16 |
2008-08-29 |
Микромет Аг |
Полипептиды с повышенной экспрессией
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
CA2580141C
(en)
|
2004-09-23 |
2013-12-10 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
US20070134243A1
(en)
|
2004-12-01 |
2007-06-14 |
Gazzard Lewis J |
Antibody drug conjugates and methods
|
US7947839B2
(en)
|
2004-12-01 |
2011-05-24 |
Genentech, Inc. |
Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
|
CA2491067A1
(en)
|
2004-12-24 |
2006-06-24 |
Stichting Katholieke Universiteit |
Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
|
CN101115771B
(zh)
*
|
2005-02-03 |
2013-06-05 |
安迪拓普有限公司 |
人类抗体和蛋白质
|
AU2006220709B2
(en)
*
|
2005-03-04 |
2012-09-06 |
Biogen Ma Inc. |
Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
|
CN1854295A
(zh)
*
|
2005-04-25 |
2006-11-01 |
上海新生源医药研究有限公司 |
卵巢癌抗独特型微抗体的生产方法
|
EP1726650A1
(en)
*
|
2005-05-27 |
2006-11-29 |
Universitätsklinikum Freiburg |
Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
|
GB2426581A
(en)
|
2005-05-27 |
2006-11-29 |
Univ Nottingham |
Immunoassay methods
|
JP2007014267A
(ja)
|
2005-07-07 |
2007-01-25 |
Toyama Univ |
B型肝炎ウイルスのHBs抗原に対するモノクローナル抗体、それに関連する遺伝子およびペプチド、並びにB型肝炎ウイルスの検定方法、B型肝炎の診断方法、治療方法
|
UA97469C2
(uk)
|
2005-07-25 |
2012-02-27 |
Емерджент Продакт Дівелопмент Сіетл, Елелсі |
Гуманізована специфічна до cd37 зв'язувальна молекула імуноглобуліну
|
US20080279850A1
(en)
|
2005-07-25 |
2008-11-13 |
Trubion Pharmaceuticals, Inc. |
B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
WO2007100385A2
(en)
|
2005-10-31 |
2007-09-07 |
Genentech, Inc. |
Macrocyclic depsipeptide antibody-drug conjugates and methods
|
US20070212331A1
(en)
|
2006-03-07 |
2007-09-13 |
Baldassare Joseph J |
Methods and compositions for selectively killing cells
|
CA2646329C
(en)
*
|
2006-03-20 |
2018-07-03 |
The Regents Of The University Of California |
Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
|
EP2001907A2
(en)
|
2006-03-21 |
2008-12-17 |
Wyeth a Corporation of the State of Delaware |
Methods and compositions for antagonism of rage
|
ES2776100T3
(es)
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
Sistema para el suministro dirigido de agentes terapéuticos
|
US7566276B2
(en)
|
2006-04-14 |
2009-07-28 |
Dogleg Right Corporation |
Multi-piece putter head having an insert
|
US20110052697A1
(en)
|
2006-05-17 |
2011-03-03 |
Gwangju Institute Of Science & Technology |
Aptamer-Directed Drug Delivery
|
US8574848B2
(en)
|
2006-09-13 |
2013-11-05 |
Oncimmune Ltd. |
Immunoassay methods
|
US20100215581A1
(en)
|
2006-10-25 |
2010-08-26 |
Koninklijke Philips Electronics N.V. |
Contrast agents for detecting prostate cancer
|
US8362217B2
(en)
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
US20100267933A1
(en)
|
2006-12-21 |
2010-10-21 |
Moya Wilson |
Purification of proteins
|
CA2682605A1
(en)
|
2007-04-18 |
2008-10-30 |
Zymogenetics, Inc. |
Single chain fc, methods of making and methods of treatment
|
BRPI0811857A2
(pt)
*
|
2007-05-14 |
2014-10-21 |
Biogen Idec Inc |
Regiões fc (scfc) de cadeia simples, polipeptídeos de aglutinação que as compreendem e métodos relacionados.
|
EP2187971A2
(en)
*
|
2007-08-01 |
2010-05-26 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
A fold-back diabody diphtheria toxin immunotoxin and methods of use
|
US8940298B2
(en)
|
2007-09-04 |
2015-01-27 |
The Regents Of The University Of California |
High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
|
NZ601827A
(en)
|
2007-10-18 |
2014-01-31 |
Bavarian Nordic Inc |
Use of mva to treat prostate cancer
|
WO2009052628A1
(en)
|
2007-10-25 |
2009-04-30 |
Viventia Biotech Inc. |
Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof
|
US9107858B2
(en)
|
2007-12-05 |
2015-08-18 |
Wisconsin Alumni Research Foundation |
Dendritic cell targeting compositions and uses thereof
|
EP2250201B1
(en)
|
2008-01-29 |
2014-04-30 |
Ludwig Institute for Cancer Research Ltd. |
Membrane transporter napi2b (slc34a2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy
|
US8742076B2
(en)
|
2008-02-01 |
2014-06-03 |
Genentech, Inc. |
Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
|
US8043830B2
(en)
|
2008-02-01 |
2011-10-25 |
The Regents Of The University Of California |
Biotin-ligase system for secretion of biotinylated protein
|
ITTO20080313A1
(it)
*
|
2008-04-22 |
2009-10-23 |
Marco Colombatti |
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi
|
TW200947474A
(en)
|
2008-05-05 |
2009-11-16 |
Ren-Huan Pan |
Manufacturing equipment and method of quadratic arc alignment dua-turret formation center, and miniature milliohm current sensors manufactured thereof
|
JP5539971B2
(ja)
|
2008-05-13 |
2014-07-02 |
ジェネンテック, インコーポレイテッド |
ビーズに基づく親和性キャプチャおよび質量分析による抗体薬剤コンジュゲートの分析
|
CN102159248B
(zh)
|
2008-07-15 |
2013-09-11 |
健泰科生物技术公司 |
蒽环类衍生物缀合物、它们的制备方法以及它们作为抗肿瘤化合物的用途
|
US20100069616A1
(en)
|
2008-08-06 |
2010-03-18 |
The Regents Of The University Of California |
Engineered antibody-nanoparticle conjugates
|
WO2010027629A2
(en)
|
2008-09-08 |
2010-03-11 |
Conocophillips Company |
System for incondensable component separation in a liquefied natural gas facility
|
WO2010037397A1
(en)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cmv immune monitoring
|
CA2740098A1
(en)
|
2008-10-10 |
2010-04-15 |
Valerie Odegard |
Tcr complex immunotherapeutics
|
WO2010043927A1
(en)
|
2008-10-13 |
2010-04-22 |
Xeptagen Spa |
Method for the preparation of immunoconjugates and use thereof
|
CA2742324A1
(en)
|
2008-10-30 |
2010-06-03 |
Caris Life Sciences Luxembourg Holdings, S.A.R.L. |
Methods for assessing rna patterns
|
CN102301002A
(zh)
|
2008-11-12 |
2011-12-28 |
卡里斯生命科学卢森堡控股有限责任公司 |
使用外来体来确定表现型的方法和系统
|
KR20110083730A
(ko)
|
2008-11-13 |
2011-07-20 |
이머전트 프로덕트 디벨롭먼트 시애틀, 엘엘씨 |
Cd37 면역치료제 병용 요법 및 이의 용도
|
WO2010074702A1
(en)
|
2008-12-16 |
2010-07-01 |
Millipore Corporation |
Purification of proteins
|
JP5432132B2
(ja)
|
2008-12-25 |
2014-03-05 |
東海ゴム工業株式会社 |
流体封入式防振装置
|
EP3543256A1
(en)
|
2009-01-12 |
2019-09-25 |
Cytomx Therapeutics Inc. |
Modified antibody compositions, methods of making and using thereof
|
ES2712732T3
(es)
*
|
2009-02-17 |
2019-05-14 |
Cornell Res Foundation Inc |
Métodos y kits para el diagnóstico de cáncer y la predicción de valor terapéutico
|
WO2010102195A2
(en)
|
2009-03-06 |
2010-09-10 |
The Johns Hopkins University |
Annexin a11 and associated genes as biomarkers for cancer
|
EP2411808B1
(en)
|
2009-03-24 |
2015-11-11 |
Biocept, Inc. |
Devices and methods of cell capture and analysis
|
JP5841046B2
(ja)
*
|
2009-04-08 |
2016-01-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
制御された血清中薬物動態を有するヒトタンパク質スキャフォールド
|
EP2424567B1
(en)
|
2009-04-27 |
2018-11-21 |
OncoMed Pharmaceuticals, Inc. |
Method for making heteromultimeric molecules
|
SG176203A1
(en)
|
2009-05-28 |
2011-12-29 |
Glaxo Group Ltd |
Il-13 binding protein
|
EP2448966B1
(en)
|
2009-07-03 |
2018-11-14 |
Avipep Pty Ltd |
Immuno-conjugates and methods for producing them
|
US8416206B2
(en)
|
2009-07-08 |
2013-04-09 |
Smart Technologies Ulc |
Method for manipulating a graphic widget in a three-dimensional environment displayed on a touch panel of an interactive input system
|
TWM383852U
(en)
|
2009-07-13 |
2010-07-01 |
Speedtech Corp |
An improvement of the universal serial bus connector
|
EP2471556A4
(en)
|
2009-10-05 |
2015-06-03 |
Canon Kk |
CONTRASTANT FOR PHOTOACUSTIC IMAGING AND PROCESS FOR PHOTOACUSTIC IMAGING THEREWITH
|
CA2782333C
(en)
|
2009-12-02 |
2019-06-04 |
Imaginab, Inc. |
J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
|
WO2011075786A1
(en)
|
2009-12-23 |
2011-06-30 |
Avipep Pty Ltd |
Immuno-conjugates and methods for producing them 2
|
PT2519543T
(pt)
|
2009-12-29 |
2016-10-07 |
Emergent Product Dev Seattle |
Proteínas de ligação de heterodímero e suas utilizações
|
JP5808349B2
(ja)
|
2010-03-01 |
2015-11-10 |
カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー |
セラノーシスのためのバイオマーカー
|
UA108227C2
(xx)
*
|
2010-03-03 |
2015-04-10 |
|
Антигензв'язуючий білок
|
US9812638B2
(en)
|
2010-03-19 |
2017-11-07 |
Globalfoundries Inc. |
Backend of line (BEOL) compatible high current density access device for high density arrays of electronic components
|
US20120144110A1
(en)
|
2010-12-02 |
2012-06-07 |
Lsi Corporation |
Methods and structure for storage migration using storage array managed server agents
|